• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

    9/25/24 11:19:00 AM ET
    $AHCO
    $LH
    Medical/Nursing Services
    Health Care
    Medical Specialities
    Health Care
    Get the next $AHCO alert in real time by email

    Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024.

    Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served as Vice President, General Manager of the Health Systems Operating Division at Labcorp (NYSE:LH). Previously, Mr. Nair served as Senior Vice President at Thrive Skilled Pediatric Care, and as Vice President of Operations at AdaptHealth (NASDAQ:AHCO). Mr. Nair graduated from the prestigious Bronx High School of Science, holds a B.A. in Business Administration from Sacramento International University, and earned his MBA in Public Accounting from the Tobin College of Business at Saint John's University.

    "We are thrilled to welcome Dino to Advantage," said Timothy Bovard, Chairperson of the Board of Advantage. "Our Board conducted an extensive search and Dino stood out as the ideal fit for us. With his extensive experience in healthcare, particularly sleep and pulmonary therapy, we are confident Dino has the skills and exemplary leadership to lead Advantage as it looks to grow and expand its ability to improve outcomes for more patients through personalized care."

    "I am excited to join the Advantage family, and lead the Company in our continued growth, building on the positive energy that has been established," Mr. Nair said. "I look forward to collaborating closely with our team to execute initiatives to drive improved patient outcomes through greater access, while delivering value to our customers and stakeholders."

    "On behalf of the Board of Directors, we would like to thank Ryan for his leadership," said Mr. Bovard. "He led the Company through some challenging times and is delivering a business poised for growth to Dino."

    About Advantage Healthcare Holdings

    Advantage is a regional leader in managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers (Sleep Labs). The Company provides a wide array of services, including Physical Therapy, Occupational Therapy, Pulmonary Rehabilitation, In-Lab Sleep Testing, Home Sleep Testing, and Remote Patient Monitoring. Advantage also runs an Accredited Sleep Technologist Education Program (A-STEP).

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240925779746/en/

    Get the next $AHCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AHCO
    $LH

    CompanyDatePrice TargetRatingAnalyst
    Labcorp Holdings Inc.
    $LH
    4/2/2025$276.00Buy
    Redburn Atlantic
    Labcorp Holdings Inc.
    $LH
    3/4/2025$250.00 → $300.00Neutral → Buy
    Citigroup
    Labcorp Holdings Inc.
    $LH
    1/7/2025$260.00 → $265.00In-line → Outperform
    Evercore ISI
    Labcorp Holdings Inc.
    $LH
    12/10/2024$265.00 → $275.00Buy
    Jefferies
    Labcorp Holdings Inc.
    $LH
    10/30/2024Hold → Buy
    HSBC Securities
    Labcorp Holdings Inc.
    $LH
    10/1/2024$235.00Neutral
    Piper Sandler
    Labcorp Holdings Inc.
    $LH
    3/25/2024$250.00Hold → Buy
    Argus
    Labcorp Holdings Inc.
    $LH
    2/26/2024$260.00Outperform
    Leerink Partners
    More analyst ratings

    $AHCO
    $LH
    SEC Filings

    See more
    • SEC Form 144 filed by Labcorp Holdings Inc.

      144 - LABCORP HOLDINGS INC. (0000920148) (Subject)

      6/3/25 11:55:38 AM ET
      $LH
      Medical Specialities
      Health Care
    • SEC Form SD filed by Labcorp Holdings Inc.

      SD - LABCORP HOLDINGS INC. (0000920148) (Filer)

      5/30/25 11:18:20 AM ET
      $LH
      Medical Specialities
      Health Care
    • SEC Form S-8 filed by Labcorp Holdings Inc.

      S-8 - LABCORP HOLDINGS INC. (0000920148) (Filer)

      5/29/25 4:09:57 PM ET
      $LH
      Medical Specialities
      Health Care

    $AHCO
    $LH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CEO Schechter Adam H sold $1,518,497 worth of shares (6,105 units at $248.73), decreasing direct ownership by 6% to 98,962 units (SEC Form 4)

      4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

      5/13/25 10:01:55 AM ET
      $LH
      Medical Specialities
      Health Care
    • EVP, Chief Legal Officer Van Der Vaart Sandra D sold $452,884 worth of shares (1,900 units at $238.36), decreasing direct ownership by 46% to 2,244 units (SEC Form 4)

      4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

      5/5/25 12:45:59 PM ET
      $LH
      Medical Specialities
      Health Care
    • SVP, Chief Accounting Officer Wilkinson Peter J sold $200,838 worth of shares (829 units at $242.26), decreasing direct ownership by 29% to 2,054 units (SEC Form 4)

      4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

      5/5/25 12:45:10 PM ET
      $LH
      Medical Specialities
      Health Care

    $AHCO
    $LH
    Financials

    Live finance-specific insights

    See more
    • AdaptHealth Corp. Announces First Quarter 2025 Results

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025. First Quarter Results and Highlights All comparisons are to the quarter ended March 31, 2024. Net revenue was $777.9 million compared to $792.5 million, a decrease of 1.8%. Net loss attributable to AdaptHealth Corp. was $7.2 million compared to net loss of $2.1 million. Adjusted EBITDA was $127.9 million compared to $158.5 million, a decrease of 19.3%. Cash flow from operations was $95.5 mi

      5/6/25 7:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Labcorp Announces 2025 First Quarter Results

      Updates Full-Year Guidance Results from Operations for first quarter 2025 versus first quarter last year:Revenue: $3.35 billion versus $3.18 billionDiluted EPS: $2.52 versus $2.69Adjusted EPS: $3.84 versus $3.68Reaffirmed Revenue and Free Cash Flow guidance, raised midpoint of adjusted EPS:Revenue guidance of 6.7% to 8.0%Adjusted EPS range of $15.70 to $16.40; midpoint raised $0.05Free Cash Flow of $1.10 billion to $1.25 billionProviding broader access to comprehensive testing and laboratory services with several transactions announced/completed year-to-dateIntroduced new tests including Labcorp Plasma Complete, a liquid biopsy test for cancer, and pTau-217/Beta Amyloid 42 Ratio test to aid

      4/29/25 6:50:00 AM ET
      $LH
      Medical Specialities
      Health Care
    • AdaptHealth Corp. Announces First Quarter 2025 Earnings Release Date and Conference Call

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2025 financial results before the opening of the financial markets on Tuesday, May 6, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-5172 (Domestic) or (203) 518-9856 (International) When prompted, reference Conference ID: AHCO1Q25 Webcast registration: Click Here Following the live

      4/21/25 4:05:00 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    $LH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

      New test offerings target solid tumors and hematologic malignancies Enhanced biopharma services support accelerated clinical trials and companion diagnostic development BURLINGTON, N.C., May 30, 2025 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and hematologic malignancies and enhanced biopharma solutions designed to accelerate clinical trials and companion diagnostic development. "Labcorp is comm

      5/30/25 7:00:00 AM ET
      $LH
      Medical Specialities
      Health Care
    • SOLVD Health Appoints Mike Aicher and Vince Cebula to Board of Directors to Support Next Phase of Growth

      SOLVD Health (SOLVD), a patient intelligence company developing cutting-edge precision solutions to deliver better health outcomes, has appointed diagnostics pioneer Mike Aicher and strategic advisor Vince Cebula to its Board of Directors. Their combined leadership in molecular diagnostics, healthcare technology, and growth-stage investment will support the company's continued expansion as it scales access to personalized health insights and accelerates development of its precision diagnostics platform. Aicher's expertise in building and scaling diagnostic platforms will be instrumental as SOLVD Health expands its personalized health solutions. He brings more than three decades of executiv

      5/12/25 9:00:00 AM ET
      $LH
      Medical Specialities
      Health Care
    • Labcorp to Webcast Its Annual Meeting of Shareholders May 15

      BURLINGTON, N.C., May 8, 2025 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 15 at 9:00 a.m. ET and can be viewed online on the Labcorp Investor Relations website. An archived replay of the webcast will be available for one year. About LabcorpLabcorp (NYSE:LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident dec

      5/8/25 4:15:00 PM ET
      $LH
      Medical Specialities
      Health Care

    $AHCO
    $LH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

      SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

      11/14/24 9:03:31 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by AdaptHealth Corp.

      SC 13G - AdaptHealth Corp. (0001725255) (Subject)

      11/13/24 9:30:46 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

      SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

      11/12/24 1:30:20 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    $LH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Redburn Atlantic initiated coverage on Labcorp Holdings Inc. with a new price target

      Redburn Atlantic initiated coverage of Labcorp Holdings Inc. with a rating of Buy and set a new price target of $276.00

      4/2/25 8:50:29 AM ET
      $LH
      Medical Specialities
      Health Care
    • Labcorp Holdings Inc. upgraded by Citigroup with a new price target

      Citigroup upgraded Labcorp Holdings Inc. from Neutral to Buy and set a new price target of $300.00 from $250.00 previously

      3/4/25 7:36:42 AM ET
      $LH
      Medical Specialities
      Health Care
    • Labcorp Holdings Inc. upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Labcorp Holdings Inc. from In-line to Outperform and set a new price target of $265.00 from $260.00 previously

      1/7/25 8:12:52 AM ET
      $LH
      Medical Specialities
      Health Care

    $AHCO
    $LH
    Leadership Updates

    Live Leadership Updates

    See more
    • SOLVD Health Appoints Mike Aicher and Vince Cebula to Board of Directors to Support Next Phase of Growth

      SOLVD Health (SOLVD), a patient intelligence company developing cutting-edge precision solutions to deliver better health outcomes, has appointed diagnostics pioneer Mike Aicher and strategic advisor Vince Cebula to its Board of Directors. Their combined leadership in molecular diagnostics, healthcare technology, and growth-stage investment will support the company's continued expansion as it scales access to personalized health insights and accelerates development of its precision diagnostics platform. Aicher's expertise in building and scaling diagnostic platforms will be instrumental as SOLVD Health expands its personalized health solutions. He brings more than three decades of executiv

      5/12/25 9:00:00 AM ET
      $LH
      Medical Specialities
      Health Care
    • AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Russell Schuster has been appointed Chief Commercial Officer, effective December 2nd, 2024. In his new role, Mr. Schuster will oversee commercial strategy and revenue generation for the Company. He is a seasoned executive with more than 25 years of experience and a proven track record of growing large businesses. Most recently, Mr. Schuster served as President of Cardinal Health Canada, where he delivered meaningful performance improvement. Over eight ye

      12/3/24 8:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Labcorp CFO Glenn Eisenberg Announces Plans to Retire

      Julia Wang Named Chief Financial Officer Beginning December 2, 2024 BURLINGTON, N.C., Nov. 19, 2024 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today that Executive Vice President and Chief Financial Officer (CFO) Glenn Eisenberg will retire from the company and Julia Wang will join on December 2, 2024, as Executive Vice President and Chief Financial Officer. Mr. Eisenberg will remain at Labcorp as Special Advisor to the CEO through April 2025 to ensure a seamless transition of his current role and assist with strategic initiatives underway within the company.

      11/19/24 7:00:00 AM ET
      $BGNE
      $LH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical Specialities